Skip to main content

Cerevel Therapeutics Holdings, Inc.

CEREDelisted Aug 1, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001805387

Cerevel Therapeutics Holdings, Inc. was delisted on Aug 1, 2024; its insiders filed their last Form 4 on Aug 5, 2024; 231 institutions reported holding it in 13F filings for Q2 2024, worth $6.42B in total; Soros Fund Management was the only superinvestor holding it.

13F holders, Q1 2026

Institutional positions in Cerevel Therapeutics Holdings, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

CERE is no longer listed, and 13F filings after Q2 2024 list far fewer holders. See Q2 2024

Institutional holders
0
−1 vs. Q4 2025
Shares held
0
−1.00K (−100.0%) vs. Q4 2025
Total value
$0
−$1.16K (−100.0%) vs. Q4 2025
New holders
0
0 more added
Sold out
1
0 more reduced

Compare with Q4 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CERE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2026: 0 institutions
Q1 2021: 62 institutionsQ2 2021: 82 institutionsQ3 2021: 94 institutionsQ4 2021: 107 institutionsQ1 2022: 107 institutionsQ2 2022: 109 institutionsQ3 2022: 115 institutionsQ4 2022: 125 institutionsQ1 2023: 119 institutionsQ2 2023: 125 institutionsQ3 2023: 119 institutionsQ4 2023: 195 institutionsQ1 2024: 210 institutionsQ2 2024: 231 institutionsQ3 2024: 2 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 1 institutionQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2026: $0
Q1 2021: $1.37BQ2 2021: $2.65BQ3 2021: $3.51BQ4 2021: $3.84BQ1 2022: $4.27BQ2 2022: $3.28BQ3 2022: $3.76BQ4 2022: $4.23BQ1 2023: $3.30BQ2 2023: $4.41BQ3 2023: $3.07BQ4 2023: $6.61BQ1 2024: $6.67BQ2 2024: $6.42BQ3 2024: $20.7KQ4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $1.16KQ1 2026: $0Q2 2026: $0
Institutions holding CERE and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20251$1.16K
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20242$20.7K
Q2 2024231$6.42B
Q1 2024210$6.67B
Q4 2023195$6.61B
Q3 2023119$3.07B
Q2 2023125$4.41B
Q1 2023119$3.30B
Q4 2022125$4.23B
Q3 2022115$3.76B
Q2 2022109$3.28B
Q1 2022107$4.27B
Q4 2021107$3.84B
Q3 202194$3.51B
Q2 202182$2.65B
Q1 202162$1.37B

Institutions, Q1 2026

Shares, value and share of portfolio for each institution holding Cerevel Therapeutics Holdings, Inc.; share changes are against Q4 2025.

Institutions holding CERE in Q1 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Meteora Capital, LLC0$00.00%−1,000−100.0%Sold out